thiol is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-01-10. Where a claim depends on a specific study, the study is described rather than over-claimed.
Glutathione is a small tripeptide composed of glutamate, cysteine, and glycine, with the unusual gamma-glutamyl linkage between glutamate and cysteine. Its cysteine thiol group makes it a major non-enzymatic antioxidant in cells. The reduced form, GSH, predominates in most intracellular compartments, while the oxidized disulfide form, GSSG, is produced when GSH reduces reactive oxygen species. Intracellular concentrations often reach millimolar levels, whereas plasma concentrations are much lower, typically in the low micromolar range. This gradient reflects active synthesis, transport, and consumption rather than passive distribution.
Synthesis occurs in two ATP-dependent steps: glutamate-cysteine ligase joins glutamate and cysteine to form gamma-glutamylcysteine, and glutathione synthetase adds glycine to complete the tripeptide. The pathway is feedback-inhibited by GSH and limited by cysteine availability, so cysteine supply often constrains production. Once formed, GSH participates in redox buffering, xenobiotic conjugation, and protein glutathionylation. Glutathione peroxidase uses GSH to reduce hydrogen peroxide and lipid peroxides, yielding GSSG, while glutathione reductase regenerates GSH using NADPH. Glutathione S-transferases conjugate electrophiles to GSH, supporting detoxification and excretion.
Because GSH is central to redox balance, its status is studied in aging, liver disease, neurodegenerative conditions, and metabolic disorders. Observational studies often report lower GSH or higher GSSG in affected tissues, but such associations do not establish that raising glutathione changes disease outcomes. Oral glutathione is digested into amino acids, and whether intact absorption occurs remains debated; precursors such as N-acetylcysteine and cysteine donors are also investigated. Regulatory agencies generally treat glutathione as a dietary supplement, not an approved drug, and clinical claims require evidence from controlled trials.
Glutathione is a small tripeptide built from glutamic acid, cysteine, and glycine. Its peptide bond between glutamate and cysteine involves the gamma-carboxyl group rather than the usual alpha-carboxyl group. This structure gives the molecule a reactive thiol on the cysteine residue. The reduced form, often abbreviated GSH, is the predominant intracellular species in many cell types. Because the thiol can donate electrons, glutathione participates in redox chemistry and in the conjugation of reactive molecules.
Cells synthesize glutathione through two ATP-dependent steps: glutamate-cysteine ligase joins glutamate and cysteine, and glutathione synthetase adds glycine to form the complete tripeptide. Breakdown occurs through gamma-glutamyl transpeptidase and subsequent peptidase reactions, forming the gamma-glutamyl cycle. Within cells, glutathione also forms a disulfide-linked dimer called GSSG when two GSH molecules react. The balance between GSH and GSSG is widely used as an indicator of oxidative conditions, although the ratio can vary by compartment and tissue.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C10H17N3O6S | Tripeptide of glutamate, cysteine, and glycine. |
| Molar mass | 307.32 g/mol | Calculated from the molecular formula. |
| Appearance | White to off-white powder | Typically crystalline or lyophilized solid. |
| Solubility | Soluble in water; insoluble in ethanol | Aqueous solutions are acidic and prone to oxidation. |
| Typical storage | -20 °C, desiccated, protect from light | Reduce exposure to oxygen and moisture. |
== Beginnings of Genentech == A young Swanson now found himself unemployed. Swanson was interviewing almost daily, attempting to find a job. However, he was still fascinated by the potential of recombinant DNA technology, and decided to cold call scientists working on the technology, with the hope that one of them would be interested in commercializing it. One of the scientists he contacted, Herbert Boyer, expressed interest but was hesitant of meeting up with Swanson at first. Boyer was an academic scientist, and was not well versed on the matters of business. Swanson convinced Boyer to meet, for a short time, at his University of California, San Francisco lab. The short meeting was extended to three hours, and Boyer came out determined to commercialize the technology he had helped pioneer. He would deal with the science behind the product, whereas Swanson would work on obtaining funds, and managing the organization as a whole. The two agreed to form a partnership, and each put down $500 to cover legal fees. Swanson made the decision to pursue the creation of the company full-time, rather than obtain a job at an established institution or company. He explains his logic in an interview: "(I told myself) "Look, I think this is important. If I don't do this, I'm not going to like myself so much for not having given it a shot." So that was what made that decision." Swanson then set out to identify their first marketable product, and quickly focused on the human protein insulin.
Due to the mutiny of the Military Police of Espírito Santo State in which the agents demanded the correction of the remuneration for inflation, along with retroactive payments, criminal gangs and drug traffickers took advantage of the situation and a crime wave of violence, carjacking and looting spread across Espírito Santo, with most public services and businesses being closed. The Espírito Santo state government called in assistance from the National Public Security Force and the Brazilian Armed Forces to restore law and order in Vitória and other cities until military policemen began to return to their duties after two weeks of strike action. By 25 February, all military policemen in Espírito Santo had ended their strikes. At least 215 people were killed in the violence.
== Biosynthesis == Gramicidin S biosynthetic pathway consists of two-enzyme of nonribosomal peptide synthases (NRPSs), gramicidin S synthetase I (GrsA) and gramicidin S synthetase II (GrsB), to give a product as a cyclic decapeptide. Within the biosynthetic pathway, there are total of five modules that specifically recognize, activate, and condense the amino acids to gramicidin S. Starting module GrsA consists of three domains: Adenylation (A) domain where it incorporates the amino acid and activates it by adenylation using ATP, Thiolation (T) domain or peptidyl carrier protein (PCP) in which the adenylated amino acid gets covalently attached to the 4´-phosphopantetheine group and this gets loaded onto the conserved serine in the T domain, Epimerization (E) domain where it epimerizes L-amino acid to D-amino acid. Starting module GrsA loads D-Phe onto the system. Second enzyme cluster GrsB contains four modules, each containing condensation (C), adenylation (A), and thiolation (T) domains and thioesterase domain (TE) at the end. C domain forms a peptide bond between two amino acids, D-Phe and L-Pro. L-Val, L-Orn, and L-Leu are incorporated sequentially by the next three modules of GrsB. After repeating the whole module synthesis once again, TE domain cyclizes and releases the two peptides and dimerize them together to form the final product.
Sources: en.wikipedia.org
Collagen alpha-2(I) chain is a protein that in humans is encoded by the COL1A2 gene. This gene encodes one of the chains for type I collagen, the fibrillar collagen found in most connective tissues. Mutations in this gene are associated with osteogenesis imperfecta, Cardiac-valvular and Arthrochlasia type Ehlers–Danlos syndrome, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for alpha-1 type I collagen, since alpha-2 is less abundant. Multiple messages for this gene result from multiple polyadenylation signals, a feature shared by most of the other collagen genes.
== Tissue distribution == Type III collagen is found as a major structural component in hollow organs such as large blood vessels, uterus and bowel. It is also found in many other tissues together with type I collagen.
Vogel, W.F., 2001. Collagen-receptor signaling in health and disease. European Journal of Dermatology 11, 506-514. White, D.J., Puranen, S., Johnson, M.S., Heino, J., 2004. The collagen receptor subfamily of the integrins. International Journal of Biochemistry & Cell Biology 36, 1405-1410.
Sources: en.wikipedia.org
== Reagan administration == President Ronald Reagan officially announced his war on drugs in October 1982. Reagan began to shift the job of drug enforcement from the state to the federal level. Reagan greatly increased the budgets of the antidrug programs in the FBI, the DEA, and the Department of Defense.
(2026) identify bone fragments and teeth from the Pleistocene strata from the Bianfu Cave (Yunnan, China) as Denisovan remains, while Ruan et al. (2026) study archaeological remains associated with Denisovan fossils from the Bianfu Cave, interpreted as indicative of specialized hunting, expedient production of stone tools and extensive use of unmodified bones by Denisovans. Hublin et al. (2026) report the discovery of new, approximately 773,000-years-old hominin fossils from Grotte à Hominidés at Thomas Quarry I in Casablanca (Morocco), close in age to Homo antecessor but morphologically distinct from members of this species, preserving a combination of primitive and derived traits seen in Eurasian archaic hominins and in Homo sapiens. Evidence from the study of a stratified sequence of lithic assemblages ranging from Acheulian to the Middle Stone Age from the Amanzi Springs archaeological site (South Africa), indicative of emergence of the Middle Stone Age in the studied area around 230,000 years ago, is presented by Blackwood et al. (2026). Evidence of consistent and specialized extraction of hornfels for the production of stone tools between 220,000 and 110,000 years ago is reported from the Jojosi site (South Africa) by Will et al. (2026). Beyene et al. (2026) report the discovery of approximately 100,000-years-old human skeletons and Middle Stone Age artifacts from the Halibee member of the Dawaitoli Formation (Ethiopia), interpreted as preserved in a wooded depositional environment with seasonal flooding. Zimmer et al.
Winemakers can track the progression of malolactic fermentation by paper chromatography or with a spectrophotometer. The paper chromatography method involves using capillary tubes to add small samples of the wine to chromatograph paper. The paper is then rolled and placed in a jar filled with a butanol solution containing bromocresol green indicator dye for several hours. After the paper is pulled out and dried, the distance of yellow-colored "splotches" from the base line denotes the presence of various acids, with tartaric being closest to the baseline followed by citric, malic, and finally lactic acids near the top of the paper. A significant limitation to paper chromatography is that it will not show exactly how much malic is still remaining in the wine, with the size of the "splotch" on the paper having no correlation to a quantitative figure. The sensitivity of the paper is also limited to a detection threshold of 100–200 mg/L while most measurements of "MLF stability" target a malic level of less than 0.03 g/L (30 mg/L). The enzymatic method allows for a quantitative measurement of both malic and lactic acids, but requires the expense of reagent kits and a spectrophotometer that can measure absorbance values at 334, 340, or 365 nm.
Sources: en.wikipedia.org
GSH is the reduced, thiol-containing form of glutathione, while GSSG is the oxidized disulfide dimer formed when two GSH molecules react. Cells maintain a high GSH-to-GSSG ratio under normal conditions. A shift toward GSSG is often interpreted as oxidative stress, though sample handling can affect the measured ratio.
No. It is a tripeptide made from three amino acids: glutamate, cysteine, and glycine. The gamma-glutamyl bond is unusual and distinguishes it from typical peptide linkages.
Most ingested glutathione is broken down in the gastrointestinal tract into its constituent amino acids. Some formulations may protect it from digestion, but intact absorption and delivery to specific tissues remain uncertain. Research continues on precursors and delivery methods.
It is a tripeptide of glutamic acid, cysteine, and glycine. The linkage between glutamate and cysteine uses the gamma-carboxyl group, which is unusual for peptides.